1715. In Vitro Antibacterial Activity of Cefiderocol against Difficult-to-treat Resistant (DTR) Gram-negative Pathogens in United States from SENTRY Antimicrobial Surveillance Program in 2020/2021

BACKGROUND: Difficult-to-treat resistant (DTR) isolates are defined as resistance to all first-line high-efficacy, low-toxicity antibiotics (penicillins, cephalosporins, carbapenems and quinolones), leaving physicians with limited treatment options. Cefiderocol (CFDC) is a siderophore cephalosporin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamano, Yoshinori, Takemura, Miki, Shortridge, Dee, Slover, Christine M, Longshaw, Christopher M, Echols, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752713/
http://dx.doi.org/10.1093/ofid/ofac492.1345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752713/
http://dx.doi.org/10.1093/ofid/ofac492.1345

Ejemplares similares